General Medicine:
Kerr DJ and Midgley,R: Can we treat cancer for a dollar a day. New England Journal of Medicine, 363:801-803, 2010
Kerr DJ and Scott M. British Lessons on Health Care Reform. Perspective, New England Journal of Medicine. 2009 Sep 24;361(13):e21.
Young AM, Billingham LJ, Begum G, Kerr DJ, Hughes AI, Rea RW, Shepherd S, Stanley A, Sweeney A, Ilde J Wheatley K, on behalf of the WARP Collaborative Group, Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial. Lancet. Feb 2009, 373, 567-574.
Lingwood R, Boyle P, Milburn A, Ngoma T, Arbuthnott J, McCaffrey R, Kerr S and Kerr D. The challenge of cancer control in Africa. Nature Reviews Cancer. 2008, Vol 8: 298-403
Mager, S R, Oomen MHA, Morente MM, Ratcliffe C, Knox K, Kerr DJ, Pezzella F, Riegman PHJ. Standard operating procedure for the collection of fresh frozen tissue samples. European Journal of Cancer. 43: 828-834, 2007.
Kerr F and Kerr DJ. Do we bear any moral responsibility to improving cancer care in Africa? Annals of Oncology. 17: 1730-1731, 2006
Khayat D, Kerr DJ. Opinion: Science and Society: A new model for cancer research in France. Nature Reviews Cancer. 645-651, 2006.
Ref: Cowley AR, Davis J, Dilworth JR, Donnelly PS, Dobson R, Nightingale A, Peach JM, Shore B, Kerr DJ, Seymour L. Fluorescence studies of the intra-cellular distribution of zinc bis (thiosemicarbazone) complexes in human cancer cells. Chem Commun, 845-847, 2005.
Cowley A R., Davis J, Dilworth J, Donnelly P, Dobson R, Nightingale A, Peach J M., Shore B, Kerr D and Seymour L. Contribution of academic research to discovery and development of medicines: current status and future opportunities. European Journal of Pharmaceutical Sciences. 24: 245-252. 2005. .
Boyle P, Ariyaratne M, Bartelink H, Baselga J, Berns A, Brawley OW, Burns H, Davidov M, Dinshaw KA, Dresler C, Eggermont AM, Gajurel D, Gordina G, Gray N, Kakizoe T, Karki BS, Kasler M, Kerr DJ, Khayat D, Kiselev A, Khuhaprema T, Klocker H, Levshin V, Martin-Moreno JM, McVie JG, Mendelsohn J, Napalkov NP, Ngoma TA, Park JG, Philip T, Potschke-Langer M, Poudal HN, Rajan B, Ringborg U, Rodger A, Seffrin JR, Shanta V, Shrestha MM, Thomas R, Tursz T, de Valeriola D, Veronesi U, Wiestler OD, Zaridze D, Zatonski W, Zeng YX. Curbing tobacco's toll starts with the professionals: World No Tobacco Day. Lancet. 2005 Jun 11-17;365(9476):1990-2
Couvreur P, Barguer D, Crommelin DJ, Duchene D, Engels JW, Kerr DJ, Krogsgaard-Larsen P, Meijer DK, Paoletti R, Wagner E; EUFEPS. EUFEPS report. Contribution of academic research to discovery and development of medicines: current status and future opportunities. Eur J Pharm Sci. 2005 Feb;24(2-3):245-52.
Knox K and Kerr DJ. Establishing a national tissue bank for surgically harvested cancer tissue. British Journal of Surgery. 91: 134-136, 2004.
Kerr DJ and Ratcliffe C. Improving service delivery through an integrated approach to translational cancer research. Eur Jour of Surgical Oncology. Vol 30, 61-63, 2004.
Kerr D J, Khayat D. The Entente Cordiale – natural and necessary. Annals of Oncology. 15: 1581, 2004
Kerr DJ. NTRAC pioneering a virtual model. The Lancet Oncology. 4:7: 393. 2003
Bevan H, Gowland B, Penny J, Berwich D, Kerr D. Redesigning Cancer Care. 2002. Brit Med Journal. 324:164-166
Spurgeon, P., Barwell, F., and Kerr, D. (2000). Waiting times for cancer patients in England after general practitioners’ referrals: retrospective national survey. British Medical Journal 320, 838-839.
Kerr; D.J. A national cancer plan for the UK. Ann-Oncol. 2000 Dec; 11(12): 1511-2
Stone, P; Richardson,A; Ream,E; Smith,A.G; Kerr,D.J; Kearney,N. Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum. Ann Oncol. 2000 Aug; 11(8): 971-5
oung A, Kerr DJ. Genetic and immunological therapy for cancer. J R Soc. Med, 93: 10-14 (2000)
Kerr DJ. World summit against cancer for the new millennium the Charter of Paris. Annals of Oncology, 11: 1-2 (2000)
Dombernowsky P, Smith I, Falkson G, Leonard R, Panasci L, Bellmunt J, Bezwoda W, Gardin G, Gudgeon A, Morgan M, Fornasiero A, Hoffman W, Michel J, Hatschek T, Tjabbes T, Chaudri HA, Hornbergery U, Trunet PF. On behalf of the Letrozole International Trials Group. Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate. J. Clin. Onc. 16, 2 :453-461 (1998).
Green S, Miles R, Kerr D. Improving delivery of cancer services – oncology site specialisation. Health Trends, Vol 30, 3: 80-85 (1998)
Mackean MJ, Kerr D, Lesko M, Svedberg A, Hansson F, Jodrell D, Cassidy J. A feasibility study of roquinimex (Linomide) and alpha interferon in patients with advanced malignant melanoma or renal carcinoma. British Journal of Cancer, 78 (12): 1620-1623 (1998)
Kerr, DJ; Griffiths, R and Edwards B Delivering cancer care: a model for the West Midlands. Brit. J. Cancer, 74: 667-669 (1996)
Hughes, MJ; Kerr, DJ; Cassidy, J; Soukop, M; McGregor, K; Blackburn, N; Yosef, H; Kaye, SB.A pilot study of combination therapy with interferon-a-2a and 5-fluorouracil in metastatic carcinoid and malignant endocrine pancreatic tumours. Annals of Oncology 7: 208-210 (1996)
Baban, DF; Murray, JA; Earl, HM; Kerr, DJ: Seymour, LW Quantitative analysis of vascular endothelial growth factor expression in chronic lymphocytic leukaemia. Int J Oncol 8 1: 29-34 (1996)
Herod, JJO; Kerr, DJ, Luesley, DM. Mechanisms of resistance to platinum chemotherapeutic agents. Contemp Rev Obstet Gynaecol 7: 25-28 (1995)
Miles, R; Kerr, DJ The Calman Report on Cancer Services. Current Obstetrics & Gynaecology 5 4 (1995)
De Takats, PG; Dunn, JA; Kerr, DJ; Morrison, JM Impact of adjuvant chemotherapy in breast cancer on response to tamoxifen at relapse. Cancer Treat Rev 19b: 11-19. (1993)
Franchesci, S; Boyle, P; La Vecchia, C; Burt, AD; Kerr, DJ; MacFarlane, GJThe epidemiology of thyroid cancer. Critical Reviews in Oncogenesis 41: 25-52 (1993)
Godden, J; Porteous, C; George, WD; Kerr, DJ.Bioassay of Transforming Growth factor-b activity in acidic protein extracts from primary breast cancer specimens. Anticancer Res 13: 427-432 (1993)
Godden, J; Leake, R; Kerr, DJ. The response of breast cancer cells to steroid and peptide growth factors. Anticancer Res. 12: 1683-1688. 1992
Kerr, DJ.Factors that make cancers grow. Science and Public Affairs: 31-36. 1992
Russell, J; Khan, MZ; Kerr, DJ; Spandidos, DA. The effect of transfection with the oncogenes H-ras, c-myc on the radiosensitivity of a mink epithelial cell line. Radiation Research 130: 113-116. 1992
Symonds, RP; Habeshaw, T; Kerr, DJ; Paul, J; Darling, A; Burnett, RA; Sotsiou, F; Linardopoulos, S; Spandidos, DA. No correlation between ras, c-myc and c-jun proto-oncogene expression and prognosis in advanced carcinoma of cervix. Eur J Cancer 28 10: 1615-1617. 1992
Smart, HE; Canney, P; Kaye, SB; Kerr, DJ. Myelofibrosis associated with seminoma. Clinical Oncology 4: 132. 1992
Knowles, S; Smart, HE; Al-Dawoud, D; Kerr, DJ. Small bowel fistula secondary to endarteritis obliterans complicating chemotherapy for small bowel lymphoma. Brit J Radiology 65: 349-350. 1992
Khan, MZ; Spandidos, DA; Kerr, DJ; McNichol, AM; Lang, JC; de Ridder, L; Freshney, RI. Oncogene transfection of mink lung cells : effect on growth characteristics in vitro and in vivo. Anticancer Res. 11: 1343-1348. 1991
Bissett, D; Kunkeler, L; Zwanenburg, I; Paul, J; Gray, C; Swan, IRC; Kerr, DJ Long-term sequalae of treatment for testicular germ cell tumours. Br J Cancer 62: 655-659. 1990
Leake, R; Kerr, D; Rinaldi, F Steroid hormones and growth factors in breast cancer. Annals NY Acad Sci : 236-241. 1990
Cunningham, D; Bradlay, CJ; Forrest, GJ; Hutcheon, AW; Adams, L; Sneddon, M;Harding, M; Kerr, DJ; Soukop, M; Kaye, SB. A randomised trial of oral nabilone and prochlorperazine compared to intravenous metaclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues.Eur J Cancer Clin Oncol 24 4: 685-689. 1988
Graham, J; Harding, M; Mill, L; Kerr, DJ; Rankin, E; Calman, KC; Kaye, SB Results of treatment of non-seminomatous germ cell tumours : 122 consecutive cases in the West of Scotland 1981-1985. Brit J Cancer 57 2: 182-185. 1988
James, G; Kerr, DJ; McLelland, A; Davies, DL. General peripheral nerve dysfunction in acromegaly: a study by conventional and novel neurophysiological techniques. Neurology, Neurosurgery and Psychiatry 50: 886-894. 1987
Kerr, DJ; Halberg, F; Sothern, R; Singh, VH; Alexander, WD. Chronobiologic quantification of thyroid hormone rhythms. Chimioterapia XII: 526-528. 1987
Kerr, DJ; Singh, VK; Alexander, WD; Beastall, GH. The effect of low dose nocturnal dopamine infusion on the circadian rhythm of TSH. Clinical Science 72: 737-741. 1987
Tumours of the diffuse endocrine system Kerr, DJ; Anderson, JR; Burt, AD.Europ J Surg Oncol 13: 189-195. 1987
Kerr, DJ; Burt, AD; Holloway, C; Beastall, G The effect of 5-fluorouracil on rat adrenal function. Medical Oncology and Tumour Pharmaco-Therapy 3 2: 101-104. 1986
Kerr, DJ; Singh, VK; McConnell, N; Tsakiris, D; Junor, B. Thyroid function and dialysate hormone loss in haemodialysis and chronic ambulatory peritoneal dialysis patients. Nephron 43: 164-169. 1986
Kerr, DJ; Burt, AD; Boyle, P; MacFarlane, GJ; Storer, AM; Brewin, TB. Prognostic factors in thyroid cancer. Brit J Cancer 54: 475-482. 1986
Kerr, DJ; Singh, VK; Alexander, WD; Sothern, RB; Halberg, I. Chronobiologic quantification of nocturnal low dose dopamine effect on circadian rhythms of thyroid related hormones and prolactin. Chronobiologia Vol XIII 3: 245-248. 1986
Kerr, DJ; Burt, AB; Brewin, TB; Boyle, P. Divergence between mortality and incidence of thyroid cancer.Lancet ii: 1932. 1985
Boyle, P; Burt, D; Kerr, DJ.The geographical pathology of thyroid cancer. Technical Report, 2692. Dana Faber Cancer Institute, Harvard University. 1985
Kerr, DJ; McAlpine, I; Dagg, JH. Pseudohyperkalaemia. Lesson of the Week, British Medical Journal, September, p890. 1985
Burt, AB; Kerr, DJ; Boyle, P; Brown, IL. Lymphoid and epithelial markers in small cell anaplastic thyroid tumours. J.Clin.Pathol. 1985 Aug; 38(8): 893-6
Alexander, WD; Kerr, DJ; Ferguson, MM.First line test of thyroid function.Lancet ii: 647. 1984
Kerr, DJ; Alexander, WD.Is the TRH test usually unnecessary? Lancet ii: 1162. 1984
Kerr, DJ; Elliot, IIL; Hillis, WS Epileptiform seizures and electroencephalographic abnormalities as manifestations of digoxin toxicity. Brit Med Journal 284: 162. 1982
PUBLISHED BOOK CHAPTERS
Midgley RS, Al-Salama H, Merrie A, Mortensen N and Kerr DJ. “Colorectal cancer: a multidisciplinary approach”. Textbook of Clinical Gastroenterology and Hepatology. In Press. 2009
Midgley RS, Kerr DJ “Systemic adjuvant therapy of colon cancer” in
“Colorectal Cancer” Ed. Rougier Ph., Bleiberg H, Wilke HJ. Publ. Martin Dunitz Ltd UK. (1997)
Midgley RS, Kerr DJ (1998) “Adjuvant chemotherapy for colorectal cancer” in “Recent Advances in Surgery” 21.Churchill Livingstone
"Chemoembolism in Cancer Therapy". D J Kerr and S B Kaye in Critical Reviews in Cancer, Ed. S D Brack, p19-39, 8 1, 1991.
"Drug Metabolism and Cancer". M A Graham, R Riley and D J Kerr. Pharmac. Ther. Vol. 51, p275-289, 1991. Ed. M J Brodie. Pergamon Press plc.
"The Effect of Angiotensin II on Tumour Blood Flow and the Delivery of Microparticulate Cytotoxic Drugs". D J Kerr, J A Goldberg, J R Anderson, N Willmott, A T Whateley, C S McArdle and J McKillop. Angiogenesis p339-345. Ed: R Steiner, PB Weisz and R Langer. Birkhauser Verby, 1992.
Graham, MA; Kerr, DJ; Workman, P.Absorption and distribution of anti-cancer drugs. In Florence AT; Salole, EG eds. Pharmaceutical aspects of cancer chemotherapy. Oxford: Butterworth-Heinemann Ltd, pp 1-26. (1993)
"The clinical evaluation of novel chemotherapeutic agents". Poole, CJ; Kerr, DJ in New Molecular targets for cancer chemotherapy. Editors Kerr, Workman, P. CRC Press : 195-212, 1994.
"P-glycoprotein, a transporter with allosterically coupled drug-acceptor sites as a target for rational drug design". Ferry, DR; Kerr, DJ in New molecular targets for chemotherapy. Editors: Kerr, DJ; Workman, P. CRC Press, pp 177-193 (1994)
“Systemic Therapy of colorectal cancer” Midgley RS, Young AM, Ferry D, Kerr DJ, (2000) in “Colorectal Cancer” Ed. McArdle C, Kerr DJ, Boyle P. Publ. ISIS Medical Media Ltd,UK.
“Principles of pharmacokinetics”. Gouyette, A; Kerr, DJ. In Peckham, Pinedo and Veronesi eds Oxford Textbook of Oncology, Oxford Press, Vol 1, Sect 4.34: 852-864 (1995)
“New and miscellaneous anticancer drugs: future developments in drug design”. Kerr, DJ; Kaye, SB. In Peckham, Pinedo & Veronesi eds. Oxford Textbook of Oncology 1.Oxford Press, pp 578-585 (1995)
"Principles Pharmacokinetique d'Agents Cytotoxique. A Gouyette and D J Kerr in Oncologie. Ed T.Tursz, Presse d’Or 1995.
"Gene-transfer therapy and pancreatic cancer". Searle,PF; Green, NK; Young, LS; Kerr, DJ; Neoptolemos, JP. in Pancreatic Cancer; Molecular and clinical advances chapter 16: 214-223. Editors: Neoptolemos, JP and Lemoine,NR. 1995
"Adjuvant chemotherapy and immunotherapy". DJ Kerr in Colorectal Cancer Chapter 10 pages 151-158. Ed: N S Williams. 1995
Morrison, J and Kerr D. Virus-directed suicide gene therapy. Cancer Therapy Molecular Targets in Tumor-host Interactions. Editor: George F Weber. Chapter 16: 363-389. 2005
Nicum S, Midgley RS, Kerr DJ (2004) Chemotherapy and Radiotherapy for Colorectal Cancer. Recent Advances in Coloproctology-Volume 2
Midgley RS, Merrie A, Mortensen N, Kerr DJ (2004) Multi-disciplinary Care of Colorectal Cancer. In Gastroenterology and Hepatology: The Modern Clinicians Guide. Ed Weinstein W, Hawkey CJ and Bosch J. Elsevier Science
Midgley RS (2002) “Systemic adjuvant therapy of colon cancer” in “Colorectal Cancer” Revised edition. Ed. Rougier Ph., Kemeny N, Bleiberg H, Wilke HJ. Publ. Martin Dunitz Ltd UK
Midgley RS, Young AM, Ferry D, Kerr DJ, (2000) “Systemic Therapy of colorectal cancer” in “Colorectal Cancer” Ed. McArdle C, Kerr DJ, Boyle P. Publ. ISIS Medical Media Ltd,UK.
Midgley RS, Kerr DJ (2000) Is adjuvant chemotherapy for colorectal cancer worthwhile? In: Challenges in colorectal cancer. Ed Scholefield J. Publ. Blackwell Science,UK. Chapter 11:149-165
Midgley RS, Kerr DJ (1998) “Adjuvant chemotherapy for colorectal cancer” in “Recent Advances in Surgery” 21.Churchill Livingstone
Midgley RS, Kerr DJ (1997) “Systemic adjuvant therapy of colon cancer” in “Colorectal Cancer” Ed. Rougier Ph., Bleiberg H, Wilke HJ. Publ. Martin Dunitz Ltd UK.
"Advances in Cancer Research" D J Kerr. Chapter 16, p314-325 in Surgical Oncology. Ed. C S McArdle. Publishers, Butterworth's Ltd.
"Adjuvant treatment of bowel cancer". DJ Kerr and RS Midgley, In: "Surgical Treatment of Colorectal Cancer". Editor Mansell
Textbook of Clinical GI/Hepato. “Colorectal cancer: a multidisciplinary approach chapter”. Midgley RS, Al-Salama HM, Merrie A, Mortensen N and Kerr D J. In press
EDITED BOOKS
"New Molecular Targets for Cancer Chemotherapy". Editors DJ Kerr, P Workman, CRC Press 1994.
"Regional Chemotherapy : Principles and Practice". Editors DJ Kerr, CS McArdle. Harwood Academic Publishers 1998.
"Clinical Textbook of colorectal Cancer". Editors DJ Kerr, CS McARdle and P. Boyle. ISIS Academic Publishers 2000.
"ABC of Colorectal Cancer", British Medical Journal Book Series, Editors DJ Kerr, AM Young and R Hobbs, 2001.
“Anticancer Therapeutic Development: from laboratory bench to bedside” – Editors B Baguley and D J Kerr, 2001
“Advances in Colorectal Cancer” Eds Kerr DJ, Bodmer WF, McArdle CS and Pignatelli M. British Medical Bulletin, 64, 2002, Oxford University Press
“Cancer biotherapy an introductory guide”. Eds, Young, Rowett, Kerr. Oxford University Press. 2006.
“Gastrointestinal Oncology: Evidence and Analysis”. Eds, McCulloch, Karpeh, Kerr, Ajani. Informa Healthcare. 2007
“Textbook of Gastrointestinal Cancer”. Eds, Jankowski, Kerr, Fong, Blackwells Publishing. 2008
“Oncology Drugs Handbook”, Oxford University Press, in preparation
“Oxford Textbook of Oncology”, Oxford University Press, in preparation
JOURNAL EDITORIAL BOARDS
-
Annals of Oncology – Editor in Chief (1998 – 2006)
-
Nature Clinical Cancer Reviews
-
Japanese Journal of Clinical Oncology
-
Seminars in Oncology
-
Molecular Oncology
-
Chinese Clinical Oncology
Share with your friends: |
